Selectis Health (GBCS) Short-term Investments (2017 - 2022)

Selectis Health has disclosed Short-term Investments across 6 years of filings, most recently posting $24387.0 for Q3 2022.

• Short-term Investments for Q3 2022 came in at $24387.0, changed 0.0% year-over-year; the trailing twelve-month figure through Sep 2022 was $24387.0 (changed 0.0% YoY), and the FY2021 annual result was $24387.0, changed 0.0% from the prior year.
• Short-term Investments came in at $24387.0 for Q3 2022 at Selectis Health, roughly flat from $24387.0 in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $307895.0 in Q2 2018 to a low of $12134.0 in Q1 2019.
• The 5-year median for Short-term Investments is $24387.0 (2019), against an average of $73348.6.
• Across the five-year window, Short-term Investments soared 12963.0% in 2018 and sank 95.76% in 2019, its largest moves.
• Selectis Health's Short-term Investments stood at $162106.0 in 2018, then plunged by 84.96% to $24387.0 in 2019, then changed by 0.0% to $24387.0 in 2020, then changed by 0.0% to $24387.0 in 2021, then changed by 0.0% to $24387.0 in 2022.
• The last three Short-term Investments figures came in at $24387.0 (Q3 2022), $24387.0 (Q2 2022), and $24387.0 (Q1 2022), per Business Quant data.